Compare ONCH & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ONCH | BDTX |
|---|---|---|
| Founded | 2024 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.4M | 220.3M |
| IPO Year | 2025 | 2020 |
| Metric | ONCH | BDTX |
|---|---|---|
| Price | $10.27 | $2.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $10.60 |
| AVG Volume (30 Days) | 37.1K | ★ 1.8M |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | N/A | ★ $70,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.07 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.16 | $1.20 |
| 52 Week High | $10.63 | $4.94 |
| Indicator | ONCH | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 28.11 |
| Support Level | N/A | $2.24 |
| Resistance Level | N/A | $2.87 |
| Average True Range (ATR) | 0.00 | 0.27 |
| MACD | 0.00 | -0.13 |
| Stochastic Oscillator | 0.00 | 23.69 |
1RT Acquisition Corp is a blank check company.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.